The delivery of insulin from aqueous and non-aqueous reservoirs governed by a glucose sensitive gel membrane.

A self regulating delivery device, responsive to glucose, has been shown to operate successfully in vitro. This comprises a gel membrane which determines the delivery rate of insulin from a reservoir. The gel consists of a synthetic polysucrose and the lectin, concanavalin A. The mechanism is one of displacement of the branched polysaccharide from the lectin receptors by incoming glucose. The gel loses its high viscosity as a result but reforms on removal of glucose, thus providing the switch controlling the drug diffusion rate. The drug does not require to be chemically modified and thus the device is adaptable to other anti-hyperglycaemic drugs. However, results here indicate that the molecular weight of the solute may be an important parameter. Others include path length, gel formulation and temperature. It had been hypothesised that the reversal might be improved by the use of a non-aqueous reservoir of insulin. However, with the use of insulin, the switching off was found to be superior to that found with other test solutes used in previous studies, irrespective of the reservoir solvent. The advantages in the use of the non-aqueous system include, however, more reproducibility in the magnitude of response and a reduced temperature sensitivity.

[1]  S. W. Kim,et al.  Self-reguiating isnssultn delivery systems II. In vitro studies , 1984 .

[2]  Pankaj Vadgama,et al.  Biosensors: recent trends. A review , 1992 .

[3]  Yoshihiro Ito,et al.  An insulin-releasing system that is responsive to glucose , 1989 .

[4]  Yie W. Chien,et al.  Novel Drug Delivery Systems , 1991 .

[5]  Y. Bae,et al.  Synthesis and characterization of soluble concanavalin A oligomer , 1993, Biotechnology and bioengineering.

[6]  K. Chong-Kook,et al.  Development of glucose-triggered pH-sensitive liposomes for a potential insulin delivery , 1994 .

[7]  T. Okano,et al.  Preparation and characterization of a glucose-responsive insulin-releasing polymer device. , 1994, Biomaterials.

[8]  M. Taylor,et al.  Overview: Biologicals & Immunologicals: Novel drug delivery systems , 1994 .

[9]  M. Manning,et al.  Structure and stability of insulin dissolved in 1-octanol , 1993 .

[10]  G. Skjåk-Bræk,et al.  Long-term reversal of diabetes by the injection of immunoprotected islets. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. W. Kim,et al.  Self-Regulated Insulin Delivery-Artificial Pancreas , 1994 .

[12]  K Mosbach,et al.  Sugar binding polymers showing high anomeric and epimeric discrimination obtained by noncovalent molecular imprinting. , 1994, Analytical biochemistry.

[13]  T. Okano,et al.  A novel drug delivery system utilizing a glucose responsive polymer complex between poly (vinyl alcohol) and poly (N-vinyl-2-pyrrolidone) with a phenylboronic acid moiety , 1992 .

[14]  B D Ratner,et al.  Glucose-sensitive membranes containing glucose oxidase: activity, swelling, and permeability studies. , 1985, Journal of biomedical materials research.

[15]  S. W. Kim,et al.  Self-regulating insulin delivery systems: III. In vivo studies , 1985 .

[16]  A. Fournier,et al.  Method for the Quantification of Alginate in Microcapsules , 1993, Cell transplantation.

[17]  Toyoichi Tanaka,et al.  Saccharide-sensitive phase transition of a lectin-loaded gel , 1991, Nature.

[18]  Insulin delivery system based on an affinity chemical valve , 1994 .

[19]  T. Okano,et al.  Glucose‐responsive complex formation between poly(vinyl alcohol) and poly(N‐vinyl‐2‐pyrrolidone) with pendent phenylboronic acid moieties , 1991 .

[20]  J. Heller Modulated release from drug delivery devices. , 1993, Critical reviews in therapeutic drug carrier systems.

[21]  P. Heinke,et al.  Primary health care of diabetic patients in a specialized outpatient setting: a DIABCARE-based analysis. , 1993, Diabete & metabolisme.

[22]  G. Soltész,et al.  Hypoglycaemia in the diabetic child. , 1993, Bailliere's clinical endocrinology and metabolism.

[23]  R. Langer,et al.  Enzymatically controlled drug delivery. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. Frier Hypoglycaemia in the diabetic adult. , 1993, Bailliere's clinical endocrinology and metabolism.

[25]  C. Saudek Future Developments in Insulin Delivery Systems , 1993, Diabetes Care.

[26]  F J Schmidt,et al.  Glucose Concentration in Subcutaneous Extracellular Space , 1993, Diabetes Care.

[27]  A S Hoffman,et al.  Formation of poly(glucosyloxyethyl methacrylate)-concanavalin A complex and its glucose-sensitivity. , 1994, Journal of biomaterials science. Polymer edition.

[28]  M A Arnold,et al.  Near-infrared spectroscopic measurement of glucose in a protein matrix. , 1993, Analytical chemistry.